fluvoxamine
fluvoxamine: sourced relationships with 2 companies · 2 clinical trials tracked · 3 FDA decisions.
fluvoxamine evidence translation
What we can confirm
3 FDA records · 2 tracked trials
What it means
What to watch
Prepared research question
What is verified about fluvoxamine, and what remains unknown?
Traceable citations · Unknowns marked
Dated Pipeline Records (2)
| Company | Dated record stage |
|---|---|
| ANI PHARMACEUTICALS INC (ANIP) Reported 2007-12-20 · Current development: unknownSource | Approved |
| Jazz Pharmaceuticals plc (JAZZ) Reported 2008-04-14 · Current development: unknownSource | Approved |
Clinical Trial Registry Records (2)
COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)
Primary endpoint: Clinical Progression to Severe Covid
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Primary endpoint: M/P ratio
FDA Decisions3 records
Frequently asked questions
Which companies have sourced relationships with fluvoxamine?
fluvoxamine has dated SEC/FDA relationship records for ANI PHARMACEUTICALS INC, Jazz Pharmaceuticals plc.
How many clinical trials involve fluvoxamine?
BioSniper tracks 2 clinical trials involving fluvoxamine.
What is fluvoxamine's latest FDA decision?
The most recent tracked FDA decision for fluvoxamine is Approval, dated April 14, 2008.